Impressive Clinical Trial Results for CA BOTANA Products

Clinical trials showed decrease in wrinkle depth and increase in skin hydration, firmness, and elasticity. End Quote

San Diego, CA (1888PressRelease) March 24, 2011 - The efficacy and performance of the latest breakthrough products formulated by R&D company Molecular Botanicals for CA BOTANA were tested in an in vivo clinical trial run by German testing institute, Derma Consult GmbH.

The products feature peptides of the highest purity along with the latest in plant stem cell technology. The active ingredients are incorporated into an advanced Alphasomal® skin care delivery system which enables encapsulated active ingredients to reach the designated area of the skin.

The tests were conducted on 20 subjects ages 36-64 for 28 days; their skin was evaluated at regular intervals to measure the effects of skin hydration, firmness, and elasticity, as well as the decrease in wrinkle depth. The products were found to have 90-100% effectiveness.

After 28 days, impressive results were seen which improve wrinkle depth and the biomechanical properties of the skin better than or as good as leading skin care products. Wrinkle depth significantly decreased by an average of 19%, skin hydration increased by 47%, skin firmness increased by 18%, and skin elasticity increased by 10%.

By repeated use of the products beyond 28 days, consumers can expect to see increased effectiveness.

About CA BOTANA
CA BOTANA, headquartered in San Diego, CA, has developed and manufactured natural and botanical skin care products for over 40 years for private label clients and for their own branded product lines Doctor D. Schwab, Ambrosia Aromatherapy, and Sea Enzyme. They have studied the effects of sea extracts, plants, herbs and vitamins, integrating these breakthrough discoveries with the latest skin care technology. For more information about CA BOTANA, visit the website at www.ca-botana.com, call 800-872-2332, or email us.

###

space

Other Related Press Releases